Skip to main content
. Author manuscript; available in PMC: 2018 Mar 15.
Published in final edited form as: Clin Cancer Res. 2017 Mar 8;23(6):1414–1421. doi: 10.1158/1078-0432.CCR-16-2439

Figure 2.

Figure 2

(A) Schematic of the trial approval process at MD Anderson. (B) Time from protocol submission to institutional review board (IRB) approval, (C) time from IRB approval to study activation, and (D) time from trial activation to first participant enrolled stratified by participant enrollment rate.